Dr. Pkdeb Kishore Deb PhD

Date of Joining: 2nd August, 2023
  • Department of Pharmaceutical Sciences and Technology, BIT Mesra, Ranchi, 835215, Jharkhand, India
  • 8822667507
    |
    8822667507

Research Areas

  • Design, Synthesis, and Development of Novel Chemical Entities (NCEs) targeting Adenosine Receptors, TB, Inflammation and Cancer.

Work Experience

  • Teaching: 12 Years
  • Research: 10 Years
  • Industry: 12 Years
<!-- THEME DEBUG --> <!-- THEME HOOK: 'field' --> <!-- FILE NAME SUGGESTIONS: ▪️ field--node--title--faculty.html.twig ✅ field--node--title.html.twig ▪️ field--node--faculty.html.twig ▪️ field--title.html.twig ▪️ field--string.html.twig ▪️ field.html.twig --> <!-- BEGIN OUTPUT from 'themes/contrib/bootstrap_barrio/templates/field/field--node--title.html.twig' --> <span class=Pkdeb " width="406" height="371" loading="lazy" >

Academic Profile

Award and Honours
Award and Honours

14

Total Award and Honours

Leadership & Institutional Service

Teaching & Mentorship

Award and Honours

View All

Recognition - World Top 2% Scientists (Single Year Category 2020-2023): Compiled and Enlisted by Stanford University, published by the Elsevier Database https://elsevier.digitalcommonsdata.com/datasets/compare/btchxktzyw

APP’s Innovative Researcher Award 2019. Awarded by “Association of Pharmacy Professionals (APP)” at APP 1st Indo-Jordan Conference, “Global Trends in Drug Design, Discovery, and Pharmaceutical Sciences”, School of Pharmaceutical Sciences, VELS University,

Best Poster Award for poster presentation on “In silico Pharmacophore Elucidation for Bicyclic Antagonists of the Human A3 Adenosine Receptor and its comparison with A2A adenosine receptor bicyclic antagonists”. 12th MPS Pharmacy Scientific Conference 201

Intellectual Property Rights (IPR)

View All

  • 4-[(substituted-1H-benzimidazol-2-ylsulfanyl)methyl]-6-substituted-2H-chromen-2-ones as larvicidal agents.

    • Date:

  • Antitubercular Compounds.

    • Date:

  • 5-(3-substitutedphenyl)-pyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,8H)-trione derivatives as anticancer agents.

    • Date:

  • 7-Benzyl-4-hydrazinyl-5,6-dimethyl-2-propyl-7H-pyrolo[2,3-d]pyrimidine as potent antimycobacterial agent.

    • Date:

  • Dimethyl-7-bromo-1-(4-substituted benzoyl)pyrrolo[1,2-a]quinoline-2,3-dicarboxylates as anti-inflammatory agents.

    • Date: